SCHEMBL547666

SCHEMBL547666

C=CCOCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formaldehyde SCHEMBL8998516 0.83
Formaldehyde SCHEMBL28195257 0.83 ALDH1A1 (0.42)
SCHEMBL15584 0.83
SCHEMBL15068452 0.83 CA1 (0.46)
SCHEMBL1799922 0.83
SCHEMBL111581 0.83
Propionaldehyde SCHEMBL11530627 0.82 ALDH1A1 (0.50)
Formic Acid SCHEMBL951745 0.81 CA1 (0.41)
Ethylene SCHEMBL8723689 0.80 CA1 (0.40)
SCHEMBL6531312 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114774102-B Degradable rope knot type temporary plugging agent for fracturing and preparation method thereof 山东科兴化工有限责任公司 2022-09-02 CN claimed
CN-114774102-A Degradable rope knot type temporary plugging agent for fracturing and preparation method thereof 山东科兴化工有限责任公司 2022-07-22 CN claimed
EP-0133272-B1 METHOD FOR THE DETERMINATION OF A PARTNER OF AN IMMUNOLOGICAL REACTION AND REAGENTS FOR PERFORMING THE METHOD Roche Diagnostics GmbH (DE) 1989-10-11 EP claimed
JP-8290952-A None JP disclosed
WO-2026087442-A1 AMINO-IMIDAZOLE ANTIBACTERIAL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2026-04-30 WO disclosed
US-12384786-B2 Cyclic molecules as Bruton's tyrosine kinase inhibitor MINGHUI PHARMACEUTICAL SHANGHAI LTD (CN) 2025-08-12 US disclosed
US-20240360082-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2024-10-31 US disclosed
EP-4373809-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS Novartis AG (CH) 2024-05-29 EP disclosed
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
US-20240084216-A1 FRAGRANCES WITH NOTE OF LILY OF THE VALLEY SYMRISE AG (DE) 2024-03-14 US disclosed
US-11891405-B2 Furo[3,4-b]pyrrole-containing BTK inhibitor CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2024-02-06 US disclosed
EP-0819190-A1 DEINKING METHOD Kao Corporation (JP) 1998-01-21 EP disclosed
EP-0411150-B1 INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME OTSUKA PHARMA CO LTD (JP) 1996-11-27 EP disclosed
JP-H08290952-A MORTAR COMPOSITION FOR PLASTERER NIPPON CEMENT CO LTD 1996-11-05 JP disclosed
WO-1996031646-A1 DEINKING METHOD KAO CORPORATION (JP) 1996-10-10 WO disclosed
EP-0555358-B1 ANTHRACYCLINE ANALOGUES BEARING LATENT ALKYLATING SUBSTITUENTS UNIV TEXAS (US) 1994-08-10 EP disclosed
US-5238938-A Nephrosis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-08-24 US disclosed
US-5196522-A Antitumor BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-03-23 US disclosed
EP-0411150-A1 INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-02-06 EP disclosed
US-4277593-A COUPLING AGENTS HERCULES INCORPORATED (US) 1981-07-07 US disclosed